DeepMed Research

Bausch & Lomb Incorporated

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1992-10-08

Employees: -

Market Cap: -

Website

Clinical Trials

Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium

Phase 4

Completed

Conditions: Age-Related Macular Degeneration
Retinal Vein Occlusion
Diabetic Macular Edema

Interventions: Drug: pegaptanib sodium injection

First Posted Date: 2012-04-09

Last Posted Date: 2021-01-08

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 131

Registration Number: NCT01573572

Locations: 🇺🇸
Wolfe Eye Clinic, Marshalltown, Iowa, United States
🇺🇸
Valley Retina Institute, Harlingen, Texas, United States
🇺🇸
Marietta Eye Clinic, Murrieta, California, United States

and more 1 locations

A Study to Evaluate the Product Performance of a Low Add MultiFocal Soft Contact Lens

Not Applicable

Completed

Conditions: Presbyopia

Interventions: Device: PureVision multifocal contact lens
Device: LD118033 contact lens

First Posted Date: 2012-02-27

Last Posted Date: 2020-09-30

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 126

Registration Number: NCT01539694

Locations: 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States

A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens

Not Applicable

Completed

Conditions: Presbyopia

Interventions: Device: Investigational contact lens
Device: PureVision contact lens

First Posted Date: 2012-01-26

Last Posted Date: 2020-09-30

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 126

Registration Number: NCT01518868

Locations: 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States

Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.

Phase 3

Completed

Conditions: Cataract

Interventions: Drug: Prednisolones acetate
Drug: Loteprednol etabonate

First Posted Date: 2011-11-21

Last Posted Date: 2019-06-11

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 107

Registration Number: NCT01475643

Locations: 🇺🇸
Bausch & Lomb Inc, Rochester, New York, United States

A Study to Evaluate the Safety and Efficacy of a New Silicone Hydrogel Contact Lens Design

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: B&L Investigational Contact Lens
Device: B&L PureVision Contact Lens

First Posted Date: 2011-10-10

Last Posted Date: 2015-02-18

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 166

Registration Number: NCT01449526

A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%

Phase 4

Completed

Conditions: Conjunctivitis, Seasonal Allergic
Conjunctivitis, Giant Papillary
Inflammation

Interventions: Drug: Prednisolone Acetate 1% Oph Susp
Drug: Loteprednol Etabonate

First Posted Date: 2011-09-21

Last Posted Date: 2019-11-19

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 140

Registration Number: NCT01437982

Locations: 🇰🇷
Bausch & Lomb Korea Ltd, Seoul, Korea, Republic of

Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)

Phase 3

Completed

Conditions: Seasonal Allergic Conjunctivitis

Interventions: Drug: Olopatadine 0.1%
Drug: Loteprednol etabonate 0.2%

First Posted Date: 2011-09-16

Last Posted Date: 2012-03-13

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 300

Registration Number: NCT01435460

Locations: 🇸🇬
Bausch & Lomb Singapore, Singapore, Singapore

Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses

Not Applicable

Terminated

Conditions: Keratoconus

Interventions: Device: KeraSoft IC Soft Contact Lenses

First Posted Date: 2011-08-15

Last Posted Date: 2014-11-25

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 12

Registration Number: NCT01416272

Locations: 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States

A Study to Evaluate the Product Performance of the PureVision®2 High Definition (HD) Contact Lens

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Spectacles
Device: PureVision2 HD contact lenses

First Posted Date: 2011-08-12

Last Posted Date: 2013-12-25

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 63

Registration Number: NCT01416142

Locations: 🇺🇸
Bausch & Lomb, Inc., Rochester, New York, United States

A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Bausch & Lomb Test lens
Device: Ciba Vision soft contact lens

First Posted Date: 2011-08-09

Last Posted Date: 2014-04-29

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 100

Registration Number: NCT01412983

Locations: 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy